- Presentations
- 2
- Markets
- 1
Praluent is a brand of Alirocumab marketed by Regeneron Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Alirocumab
- Brand owner
- Regeneron Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 150 mg/1 mL injection, 75 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Praluent 150 mg/1 mL injectionSubcutaneous Cold chain | Regeneron Pharmaceuticals | US FDA | Available on request |
| Praluent 75 mg/1 mL injectionSubcutaneous Cold chain | Regeneron Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Praluent
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.